A canine conditionally replicating adenovirus for evaluating oncolytic virotherapy in a syngeneic animal model

Akseli Hemminki, Anna Kanerva, Eric J. Kremer, Gerd J. Bauerschmitz, Bruce F. Smith, Bin Liu, Minghui Wang, Renee A. Desmond, Anne Keriel, Brian Barnett, Henry J. Baker, Gene P. Siegal, David T. Curiel

Research output: Contribution to journalArticle

83 Scopus citations

Abstract

Oncolytic adenoviruses, which selectively replicate in and subsequently kill cancer cells, have emerged as a promising approach for treatment of tumors resistant to other modalities. Although preclinical results have been exciting, single-agent clinical efficacy has been less impressive heretofore. The immunogenicity of adenoviruses, and consequent premature abrogation of replication, may have been a partial reason. Improving the oncolytic potency of agents has been hampered by the inability to study host-vector interactions in immune-competent systems, since human serotype adenoviruses do not productively replicate in animal tissues. Therefore, approaches such as immunomodulation, which could result in sustained replication and subsequently increased oncolysis, have not been studied. Utilizing the osteocalcin promoter for restricting the replication of a canine adenovirus to dog osteosarcoma cells, we generated and tested the first nonhuman oncolytic adenovirus. This virus effectively killed canine osteosarcoma cells in vitro and yielded a therapeutic benefit in vivo. Canine osteosarcoma is the most frequent malignant disease in large dogs, with over 8000 cases in the United States annually, and there is no curative treatment. Therefore, immunomodulation for increased oncolytic potency could be studied with clinical trials in this population. This could eventually translate into human trials.

Original languageEnglish
Pages (from-to)163-173
Number of pages11
JournalMolecular Therapy
Volume7
Issue number2
DOIs
StatePublished - Feb 1 2003
Externally publishedYes

Keywords

  • Adenovirus
  • Biological therapy
  • Dogs
  • Gene therapy
  • Humans
  • Immunosuppressive agents
  • Neoplasms
  • Osteocalcin
  • Osteosarcoma
  • Virus replication

Fingerprint Dive into the research topics of 'A canine conditionally replicating adenovirus for evaluating oncolytic virotherapy in a syngeneic animal model'. Together they form a unique fingerprint.

  • Cite this

    Hemminki, A., Kanerva, A., Kremer, E. J., Bauerschmitz, G. J., Smith, B. F., Liu, B., Wang, M., Desmond, R. A., Keriel, A., Barnett, B., Baker, H. J., Siegal, G. P., & Curiel, D. T. (2003). A canine conditionally replicating adenovirus for evaluating oncolytic virotherapy in a syngeneic animal model. Molecular Therapy, 7(2), 163-173. https://doi.org/10.1016/S1525-0016(02)00049-7